Sargent Investment Group, LLC Cytosorbents Corp Transaction History
Sargent Investment Group, LLC
- $616 Million
- Q4 2024
A detailed history of Sargent Investment Group, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Sargent Investment Group, LLC holds 1,248,863 shares of CTSO stock, worth $1.25 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
1,248,863
Previous 1,626,247
23.21%
Holding current value
$1.25 Million
Previous $2.44 Million
53.96%
% of portfolio
0.18%
Previous 0.45%
Shares
26 transactions
Others Institutions Holding CTSO
# of Institutions
56Shares Held
16.3MCall Options Held
15.4KPut Options Held
0-
Avenir Corp Washington, DC2.98MShares$2.98 Million0.45% of portfolio
-
Skylands Capital, LLC2.76MShares$2.76 Million0.6% of portfolio
-
Granahan Investment Management, LLC Waltham, MA2.09MShares$2.09 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.95 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.78MShares$1.78 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $43.6M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...